Walt Linscott

Walt Linscott

Director/Miembro de la Junta en MEDESIS PHARMA S.A. .

Fortuna: 95 790 $ al 31/05/2026

66 años
Health Technology
Consumer Services
Commercial Services

Perfil

Walt A. Linscott is currently a Member of the Supervisory Board at Medesis Pharma SA since 2022.
Former roles include Secretary & General Counsel at Solvay Pharmaceuticals, Inc. from 2001 to 2005; Associate & Partner at Thompson Hine LLP from 1990 to 2001 and again from 2005 to 2010; Secretary & General Counsel at Carestream Health, Inc. from 2011 to 2015; Secretary & General Counsel at Cocrystal Pharma, Inc. from 2015 to 2017; President, COO & General Counsel at Treiber Therapeutics, Inc. in 2017; Chief Business Officer at Intec Pharma Ltd. from 2018 to 2021; and Chief Operating Officer at Indaptus Therapeutics, Inc. from 2023 to 2026.
Education includes graduate degrees from the University of Oxford, the University of Cambridge, and the University of Dayton School of Law, and an undergraduate degree from Syracuse University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
21/01/2026 54.426 ( 0,05 % ) 95 790 $ 31/05/2026

Cargos activos de Walt Linscott

EmpresasCargoInicio
MEDESIS PHARMA S.A. Director/Miembro de la Junta 27/10/2022

Antiguos cargos conocidos de Walt Linscott.

EmpresasCargoFin
INDAPTUS THERAPEUTICS, INC. Director de Operaciones 01/06/2026
Director Administrativo 01/07/2018
Treiber Therapeutics, Inc.
Presidente 01/10/2017
COCRYSTAL PHARMA, INC. Consejero General 01/03/2017
Consejero General 01/01/2015
Ver el detalle de la experiencia de Walt Linscott.

Formación de Walt Linscott.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

38

Relaciones de 1er grado

12

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas12

Health Technology

Consumer Services

Consumer Services

Commercial Services

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Treiber Therapeutics, Inc.

-40%: ¡Descubre las mejores inversiones del futuro con las herramientas para suscriptores!
d
:
:
APROVECHAR LA PROMOCIÓN